Cargando…
Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive brain tumor in adults, in which chemokines are often upregulated and may play pivotal roles in their development and progression. Chemokines are a large subfamily of cytokines with leukocyte chemotactic activities involved in various t...
Autores principales: | Gao, Wenqing, Li, Yuanyuan, Zhang, Teng, Lu, Jianglong, Pan, Jiasong, Qi, Qi, Dong, Siqi, Chen, Xiangjun, Su, Zhipeng, Li, Jixi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059990/ https://www.ncbi.nlm.nih.gov/pubmed/35509325 http://dx.doi.org/10.2147/JIR.S357787 |
Ejemplares similares
-
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer
por: Ma, Rufei, et al.
Publicado: (2023) -
Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma
por: Liu, Ruifei, et al.
Publicado: (2022) -
C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis
por: Wang, Jing, et al.
Publicado: (2023) -
E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF induced cell necrosis
por: Mei, Pucheng, et al.
Publicado: (2021) -
Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21
por: Unver, Nese
Publicado: (2021)